THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
- 19/12/2014 : RT @s_liege: First students given access to the @Eu2P eLearning platform for the pilot #SafeSciMET course under @IMI_JU #imitrain project f…
- 19/12/2014 : RT @UBIOPRED: U-BIOPRED patient reps take part in European Medicines training day. Read Val's report at http://t.co/CRqhsGFZ0t. @EMA_News
- 19/12/2014 : RT @Open_PHACTS: Some great examples of how Open PHACTS can help solve drug discovery problems: http://t.co/aMSH6d4gPs